Mark Baldry - Net Worth and Insider Trading
Mark Baldry Net Worth
The estimated net worth of Mark Baldry is at least $26,750 dollars as of 2024-11-05. Mark Baldry is the Chief Commercial Officer of X4 Pharmaceuticals Inc and owns about 48,509 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $26,750. Details can be seen in Mark Baldry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Baldry has not made any transactions after 2024-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Baldry
Mark Baldry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Baldry owns 3 companies in total, including WAVE Life Sciences Ltd (WVE) , Amicus Therapeutics Inc (FOLD) , and X4 Pharmaceuticals Inc (XFOR) .
Click here to see the complete history of Mark Baldry’s form 4 insider trades.
Insider Ownership Summary of Mark Baldry
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
WVE | WAVE Life Sciences Ltd | 2019-08-05 | Chief Commerical Officer |
FOLD | Amicus Therapeutics Inc | 2015-06-01 | VP Global Marketing |
XFOR | X4 Pharmaceuticals Inc | 2024-10-07 | Chief Commercial Officer |
Mark Baldry Latest Holdings Summary
Mark Baldry currently owns a total of 1 stock. Mark Baldry owns 48,509 shares of X4 Pharmaceuticals Inc (XFOR) as of October 7, 2024, with a value of $26,750.
Latest Holdings of Mark Baldry
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals Inc | 2024-10-07 | 48,509 | 0.55 | 26,750 |
Holding Weightings of Mark Baldry
Mark Baldry Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Baldry has made a total of 2 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in X4 Pharmaceuticals Inc is the sale of 11,127 shares on October 7, 2024, which brought Mark Baldry around $6,454.
Insider Trading History of Mark Baldry
- 1
Mark Baldry Trading Performance
Mark Baldry Ownership Network
Ownership Network List of Mark Baldry
Ownership Network Relation of Mark Baldry
Mark Baldry Owned Company Details
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Mark Baldry is the Chief Commerical Officer of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include See Remarks Chris Francis , director & See Remarks Paul Bolno , and 10 percent owner Plc Glaxosmithkline .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Mark Baldry made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 69,838 shares made by Kyle Moran , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 364,822 shares of WAVE Life Sciences Ltd (WVE) in total and bought 2,791,930 shares, with a net purchase of 2,427,108 shares. During the past 18 months, 417,514 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,674,416 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
Mark Baldry Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Baldry. You might contact Mark Baldry via mailing address: C/o Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury Nj 08512.